This biotech player is firing on all cylinders.

Cystic fibrosis is an incurable genetic disorder. Since 2020, a treatment known as triple therapy has addressed the ...

People with cystic fibrosis do not usually have a higher risk of COVID-19 when compared to people without this condition. They also typically have an infection course similar to people without cystic ...

Supportive therapy, like medications to help open the airways and heal infections, can help you live a healthier life and meet many of the challenges of this inherited respiratory condition. Share on ...

KIT2014 is a novel inhaled peptide therapy being developed for respiratory diseases including chronic obstructive pulmonary ...

For decades, lung disease has been the most visible and life-threatening part of cystic fibrosis. People might picture chronic (long-term) cough, breathlessness, recurrent chest infections and oxygen ...

Nonsense mutations are estimated to cause about 11 percent of inherited genetic disorders. Those disorders number in the ...

Alyftrek (vanzacaftor/tezacaftor/deutivacaftor) is a combination medicine approved by the FDA in 2024. Alyftrek is approved to treat people ages 6 and older who have ...

Breathing disorders are common in the U.S. with conditions like COPD affecting some 7% of the population and asthma affecting another 10%. Digestive conditions like GERD, acid reflux, Celiac disease ...

Defective CFTR protein, responsible for Cystic Fibrosis (CF), is highly expressed in pancreatic ductal epithelial cells (PDECs) but their impact on insulin secreting pancreatic islets is not fully ...